Pirro, F. (2025) “Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy”, Dermatology Practical & Conceptual, 15(1), p. 4838. doi:10.5826/dpc.1501a4838.